The global synthetic biology technology market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for biofuels and chemicals, growing need for healthcare products, and increasing research in the field of synthetic biology.
The global synthetic biology technology market is segmented on the basis of type into oligonucleotide synthesis, DNA synthesis, standardized DNA parts, and synthetic genes. The oligonucleotide synthesis segment accounted for the largest share in 2018 owing to its wide application in various fields such as agriculture and healthcare. The DNA synthesis segment accounted for the second-largest share due to its wide application in various fields such as agriculture and biofuels production.
On the basis of application, this market is divided into agriculture, chemicals & pharmaceuticals (including biologics), biofuels & energy production (including renewable fuels), and healthcare (including diagnostics). Agriculture was estimated to account for a significant share in 2018 owing to its wide applications across different industries including food production & processing industry; animal feed industry; plant breeding industry; crop protection industry; etc, which are driving growth of this sector globally. .
Some Of The Growth Factors Of This Market:
- Synthetic Biology Technology Market Growth Factors:.
Industry Growth Insights published a new data on “Synthetic Biology Technology Market”. The research report is titled “Synthetic Biology Technology Market research by Types (Oligonucleotide Synthesis, DNA Synthesis, Standardized DNA Parts, Synthetic Genes, Other), By Applications (Agriculture, Chemicals, Biofuels, Healthcare), By Players/Companies Thermo Fisher, Novozymes, Merck KGaA, Intrexon, Agilent, Amyris, Genscript Biotech, Ginkgo Bioworks, Integrated DNA, New England Biolabs, Synthetic Genomics, Twist Bioscience”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Synthetic Biology Technology Market Research Report
By Type
Oligonucleotide Synthesis, DNA Synthesis, Standardized DNA Parts, Synthetic Genes, Other
By Application
Agriculture, Chemicals, Biofuels, Healthcare
By Companies
Thermo Fisher, Novozymes, Merck KGaA, Intrexon, Agilent, Amyris, Genscript Biotech, Ginkgo Bioworks, Integrated DNA, New England Biolabs, Synthetic Genomics, Twist Bioscience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Synthetic Biology Technology Market Report Segments:
The global Synthetic Biology Technology market is segmented on the basis of:
Types
Oligonucleotide Synthesis, DNA Synthesis, Standardized DNA Parts, Synthetic Genes, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Agriculture, Chemicals, Biofuels, Healthcare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Novozymes
- Merck KGaA
- Intrexon
- Agilent
- Amyris
- Genscript Biotech
- Ginkgo Bioworks
- Integrated DNA
- New England Biolabs
- Synthetic Genomics
- Twist Bioscience
Highlights of The Synthetic Biology Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oligonucleotide Synthesis
- DNA Synthesis
- Standardized DNA Parts
- Synthetic Genes
- Other
- By Application:
- Agriculture
- Chemicals
- Biofuels
- Healthcare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Synthetic Biology Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Synthetic biology technology is a field of engineering that uses biotechnology to create or modify living cells and tissues in order to create new, artificial life forms.
Some of the major companies in the synthetic biology technology market are Thermo Fisher, Novozymes, Merck KGaA, Intrexon, Agilent, Amyris, Genscript Biotech, Ginkgo Bioworks, Integrated DNA, New England Biolabs, Synthetic Genomics, Twist Bioscience.
The synthetic biology technology market is expected to grow at a compound annual growth rate of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Synthetic Biology Technology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Synthetic Biology Technology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Synthetic Biology Technology Market - Supply Chain
4.5. Global Synthetic Biology Technology Market Forecast
4.5.1. Synthetic Biology Technology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Synthetic Biology Technology Market Size (000 Units) and Y-o-Y Growth
4.5.3. Synthetic Biology Technology Market Absolute $ Opportunity
5. Global Synthetic Biology Technology Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Synthetic Biology Technology Market Size and Volume Forecast by Type
5.3.1. Oligonucleotide Synthesis
5.3.2. DNA Synthesis
5.3.3. Standardized DNA Parts
5.3.4. Synthetic Genes
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Synthetic Biology Technology Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Synthetic Biology Technology Market Size and Volume Forecast by Application
6.3.1. Agriculture
6.3.2. Chemicals
6.3.3. Biofuels
6.3.4. Healthcare
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Synthetic Biology Technology Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Synthetic Biology Technology Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Synthetic Biology Technology Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Synthetic Biology Technology Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Synthetic Biology Technology Demand Share Forecast, 2019-2029
9. North America Synthetic Biology Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Synthetic Biology Technology Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Synthetic Biology Technology Market Size and Volume Forecast by Application
9.4.1. Agriculture
9.4.2. Chemicals
9.4.3. Biofuels
9.4.4. Healthcare
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Synthetic Biology Technology Market Size and Volume Forecast by Type
9.7.1. Oligonucleotide Synthesis
9.7.2. DNA Synthesis
9.7.3. Standardized DNA Parts
9.7.4. Synthetic Genes
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Synthetic Biology Technology Demand Share Forecast, 2019-2029
10. Latin America Synthetic Biology Technology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Synthetic Biology Technology Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Synthetic Biology Technology Market Size and Volume Forecast by Application
10.4.1. Agriculture
10.4.2. Chemicals
10.4.3. Biofuels
10.4.4. Healthcare
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Synthetic Biology Technology Market Size and Volume Forecast by Type
10.7.1. Oligonucleotide Synthesis
10.7.2. DNA Synthesis
10.7.3. Standardized DNA Parts
10.7.4. Synthetic Genes
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Synthetic Biology Technology Demand Share Forecast, 2019-2029
11. Europe Synthetic Biology Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Synthetic Biology Technology Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Synthetic Biology Technology Market Size and Volume Forecast by Application
11.4.1. Agriculture
11.4.2. Chemicals
11.4.3. Biofuels
11.4.4. Healthcare
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Synthetic Biology Technology Market Size and Volume Forecast by Type
11.7.1. Oligonucleotide Synthesis
11.7.2. DNA Synthesis
11.7.3. Standardized DNA Parts
11.7.4. Synthetic Genes
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Synthetic Biology Technology Demand Share, 2019-2029
12. Asia Pacific Synthetic Biology Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Synthetic Biology Technology Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Synthetic Biology Technology Market Size and Volume Forecast by Application
12.4.1. Agriculture
12.4.2. Chemicals
12.4.3. Biofuels
12.4.4. Healthcare
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Synthetic Biology Technology Market Size and Volume Forecast by Type
12.7.1. Oligonucleotide Synthesis
12.7.2. DNA Synthesis
12.7.3. Standardized DNA Parts
12.7.4. Synthetic Genes
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Synthetic Biology Technology Demand Share, 2019-2029
13. Middle East & Africa Synthetic Biology Technology Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Synthetic Biology Technology Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Synthetic Biology Technology Market Size and Volume Forecast by Application
13.4.1. Agriculture
13.4.2. Chemicals
13.4.3. Biofuels
13.4.4. Healthcare
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Synthetic Biology Technology Market Size and Volume Forecast by Type
13.7.1. Oligonucleotide Synthesis
13.7.2. DNA Synthesis
13.7.3. Standardized DNA Parts
13.7.4. Synthetic Genes
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Synthetic Biology Technology Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Synthetic Biology Technology Market: Market Share Analysis
14.2. Synthetic Biology Technology Distributors and Customers
14.3. Synthetic Biology Technology Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novozymes
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck KGaA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Intrexon
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amyris
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Genscript Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ginkgo Bioworks
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Integrated DNA
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. New England Biolabs
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Synthetic Genomics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Twist Bioscience
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
